Manuela Rizzo

1.3k total citations
28 papers, 378 citations indexed

About

Manuela Rizzo is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Manuela Rizzo has authored 28 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in Manuela Rizzo's work include Multiple Myeloma Research and Treatments (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Manuela Rizzo is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Manuela Rizzo collaborates with scholars based in Italy, Netherlands and Germany. Manuela Rizzo's co-authors include Francesco Lo‐Coco, Luca Maurillo, Chiara Sarlo, Francesco Buccisano, Giovanni Del Poeta, William Arcese, Benedetta Neri, Emanuele Ammatuna, Paolo de Fabritiis and Micol Quaresima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Manuela Rizzo

24 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Rizzo Italy 7 186 133 112 110 85 28 378
Granada Perea Spain 8 109 0.6× 65 0.5× 91 0.8× 74 0.7× 28 0.3× 12 278
Waleed Sabry Canada 10 143 0.8× 93 0.7× 32 0.3× 98 0.9× 17 0.2× 23 266
Allison Winter United States 8 53 0.3× 41 0.3× 100 0.9× 117 1.1× 16 0.2× 39 221
Yasufumi Matsuda Japan 10 65 0.3× 93 0.7× 34 0.3× 70 0.6× 18 0.2× 27 259
Ozan Salim Türkiye 11 84 0.5× 44 0.3× 42 0.4× 52 0.5× 24 0.3× 46 271
Rupali Roy United States 6 52 0.3× 114 0.9× 111 1.0× 209 1.9× 10 0.1× 14 382
Amr Hanbali United States 9 104 0.6× 108 0.8× 25 0.2× 74 0.7× 28 0.3× 43 301
Amandeep Godara United States 8 60 0.3× 137 1.0× 20 0.2× 86 0.8× 16 0.2× 50 259
Marco Santoro Italy 13 150 0.8× 89 0.7× 31 0.3× 50 0.5× 11 0.1× 48 386
Jean‐Pierre Vilque France 10 78 0.4× 26 0.2× 72 0.6× 126 1.1× 15 0.2× 18 254

Countries citing papers authored by Manuela Rizzo

Since Specialization
Citations

This map shows the geographic impact of Manuela Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Rizzo more than expected).

Fields of papers citing papers by Manuela Rizzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Rizzo. The network helps show where Manuela Rizzo may publish in the future.

Co-authorship network of co-authors of Manuela Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Rizzo. A scholar is included among the top collaborators of Manuela Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Rizzo. Manuela Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizzo, Manuela, et al.. (2025). Microfluidics unveils role of gravity and shear stress on Pseudomonas fluorescens motility and biofilm growth. npj Biofilms and Microbiomes. 11(1). 122–122. 2 indexed citations
4.
Riccio, Eleonora, Anna Sannino, Ivana Capuano, et al.. (2024). Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study. Journal of Nephrology. 37(4). 1077–1084.
5.
Riccio, Eleonora, Ivana Capuano, Pasquale Buonanno, et al.. (2022). RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study. Frontiers in Cardiovascular Medicine. 9. 824095–824095. 17 indexed citations
6.
Pascale, Maria Rosaria, et al.. (2022). EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE LOW-DOSE PRE-PHASE CHEMOTHERAPY IN DIFFUSE LARGE B CELL LYMPHOMA WITH GASTROINTESTINAL INVOLVEMENT. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022017–e2022017. 1 indexed citations
8.
Ianniello, Zaira, Lavinia Ceci Ginistrelli, Marcella Marchioni, et al.. (2021). New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia. Cell Death and Disease. 12(10). 870–870. 34 indexed citations
9.
Guida, Bruna, et al.. (2021). Ketogenic diet in ADPKD patient. PharmaNutrition. 16. 100267–100267. 1 indexed citations
10.
Pisani, A, et al.. (2020). COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?. ˜The œNephron journals/Nephron journals. 144(8). 383–385. 5 indexed citations
11.
Riccio, Eleonora, et al.. (2020). Impact of COVID-19 pandemic on CKD outpatient management. Clinical Nephrology. 95(2). 112–114. 1 indexed citations
12.
Gurnari, Carmelo, Luca Franceschini, Lucia Anemona, et al.. (2018). Recurrent Sweet's syndrome in a patient with multiple myeloma. Clinical Case Reports. 6(10). 1958–1960. 3 indexed citations
13.
Cicconi, Laura, Massimo Breccia, Luca Franceschini, et al.. (2018). Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy. Annals of Hematology. 97(10). 1797–1802. 19 indexed citations
14.
Gurnari, Carmelo, Paola Panetta, Emiliano Fabiani, et al.. (2017). Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia. Molecular and Clinical Oncology. 8(3). 463–465. 4 indexed citations
15.
Pieri, Massimo, Alessandro De Stefano, Luca Franceschini, et al.. (2015). Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence‐Jones in nephelometry?. British Journal of Haematology. 175(4). 733–735. 4 indexed citations
16.
17.
Maurillo, Luca, Francesco Buccisano, Maria Ilaria Del Principe, et al.. (2008). Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia. Journal of Clinical Oncology. 26(30). 4944–4951. 125 indexed citations
18.
Rizzo, Manuela, Gaetano Magro, P Castaldo, & Luigi Tucci. (2004). Granulocytic sarcoma (chloroma) in HIV patient: a report. Forensic Science International. 146. S57–S58. 5 indexed citations
19.
Martelli, Maurizio, Filíppo Gherlinzoni, Amalia De Renzo, et al.. (2003). Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial. Journal of Clinical Oncology. 21(7). 1255–1262. 102 indexed citations
20.
Donato, Alberto Di, et al.. (1993). The Determinants of the Dimeric Structure of Seminal Ribonuclease Are Located in Its N-Terminal Region. Biochemical and Biophysical Research Communications. 194(3). 1440–1445. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026